Lv1
10 积分 2024-04-20 加入
Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review
1天前
已完结
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
1天前
已完结
Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus
1天前
已完结
PNPLA3 variation and kidney disease
1天前
已完结
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis
2天前
已完结
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus
2天前
已完结
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
2天前
已完结
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
4天前
已关闭
Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
4天前
已完结
Trials and tribulations of cell therapy for heart failure: an update on ongoing trials
4天前
已完结
皖公网安备34019202002308
